Innovation Network

The scientific and medical challenges addressing high unmet medical need are enormous. Roche has gained access to innovation by optimising a network of globally distributed research sites and strategic alliances like Genentech and Chugai. Other external collaborations with industry and academia are actively supporting our portfolio as well.

Setting up this network has been successful, but what is most important is how we actually manage it. We have focused on specific therapeutic areas at our Research sites and avoid overlap of programs through Joint Research Committees. Our approach to innovation, external and internal, has given us the power to continue with outstanding achievements in a difficult environment.

Pharma Partnering focus on creating important new partnerships through which we gain access to valuable innovative ideas and technologies.

Our global systems enable our innovation centers to be thriving and we manage this mainly through visibility and metrics. We have set up common standards, and common understandings of the risks and opportunities in their standards.

Roche has established a class-leading IT system that allows exchange of knowledge around the globe within hours of the experiment being finished. This knowledge leads to prediction and ultimately to better medicines. The distinguishing factor is how we manage this global group and how we allow all partners to access science and innovation in a way that suits them best.